title: Intraindividual response to treatment with pirfenidone in idiopathic pulmonary fibrosis.
authors.affiliation: 1 Agaplesion Pneumologische Klinik Waldhof-Elgershausen Greifenstein, Germany.
authors.forename: Benjamin
authors.initials: B
authors.lastname: Loeh
authors.forename: Fotios
authors.initials: F
authors.lastname: Drakopanagiotakis
authors.forename: Gian Piero
authors.initials: GP
authors.lastname: Bandelli
authors.forename: Daniel
authors.initials: D
authors.lastname: von der Beck
authors.forename: Silke
authors.initials: S
authors.lastname: Tello
authors.forename: Elisa
authors.initials: E
authors.lastname: Cordani
authors.forename: Elvira
authors.initials: E
authors.lastname: Rizza
authors.forename: Laura
authors.initials: L
authors.lastname: Barrocu
authors.forename: Philipp
authors.initials: P
authors.lastname: Markart
authors.forename: Werner
authors.initials: W
authors.lastname: Seeger
authors.forename: Andreas
authors.initials: A
authors.lastname: Guenther
authors.forename: Carlo
authors.initials: C
authors.lastname: Albera
mesh_terms: D000284:Administration, Oral; D000368:Aged; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D000933:Antifibrinolytic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D005858:Germany; D006801:Humans; D054990:Idiopathic Pulmonary Fibrosis / Q000188:drug therapy*; D007558:Italy; D008297:Male; D008875:Middle Aged; D011728:Pyridones / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D012189:Retrospective Studies; D014109:Total Lung Capacity / Q000187:drug effects; D016896:Treatment Outcome; D014797:Vital Capacity / Q000187:drug effects
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D000933:Antifibrinolytic Agents; D011728:Pyridones; C093844:pirfenidone